Wells Fargo’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.7M | Sell |
77,138
-13,802
| -15% | -$6.87M | 0.01% | 1019 |
|
|
2025
Q4 | $44.3M | Buy |
90,940
+12,819
| +16% | +$5.97M | 0.01% | 1005 |
|
|
2025
Q3 | $32.7M | Sell |
78,121
-29,605
| -27% | -$9.96M | 0.01% | 1159 |
|
|
2025
Q2 | $31M | Buy |
107,726
+33,649
| +45% | +$10.1M | 0.01% | 1117 |
|
|
2025
Q1 | $22.8M | Sell |
74,077
-2,193
| -3% | -$752K | 0.01% | 1241 |
|
|
2024
Q4 | $26.9M | Buy |
76,270
+55
| +0.1% | +$20.2K | 0.01% | 1156 |
|
|
2024
Q3 | $27.3M | Sell |
76,215
-8,932
| -10% | -$3.02M | 0.01% | 1106 |
|
|
2024
Q2 | $27.1M | Buy |
85,147
+21,684
| +34% | +$5.74M | 0.01% | 1064 |
|
|
2024
Q1 | $14.6M | Buy |
63,463
+16,239
| +34% | +$3.66M | ﹤0.01% | 1453 |
|
|
2023
Q4 | $10.4M | Sell |
47,224
-7,281
| -13% | -$1.68M | ﹤0.01% | 1679 |
|
|
2023
Q3 | $12.3M | Buy |
54,505
+886
| +2% | +$204K | ﹤0.01% | 1415 |
|
|
2023
Q2 | $11.8M | Buy |
53,619
+73
| +0.1% | +$16.2K | ﹤0.01% | 1482 |
|
|
2023
Q1 | $12M | Buy |
53,546
+4,410
| +9% | +$1.09M | ﹤0.01% | 1464 |
|
|
2022
Q4 | $13.7M | Sell |
49,136
-24,494
| -33% | -$6.18M | ﹤0.01% | 1345 |
|
|
2022
Q3 | $15.4M | Buy |
73,630
+8,263
| +13% | +$1.85M | 0.01% | 1237 |
|
|
2022
Q2 | $15.4M | Sell |
65,367
-34,480
| -35% | -$7.01M | ﹤0.01% | 1290 |
|
|
2022
Q1 | $17.9M | Buy |
99,847
+17,915
| +22% | +$3.41M | ﹤0.01% | 1379 |
|
|
2021
Q4 | $17.7M | Sell |
81,932
-350,171
| -81% | -$68.7M | ﹤0.01% | 1425 |
|
|
2021
Q3 | $79.8M | Buy |
432,103
+156,299
| +57% | +$30.8M | 0.02% | 778 |
|
|
2021
Q2 | $49.5M | Sell |
275,804
-68,786
| -20% | -$13.1M | 0.01% | 1067 |
|
|
2021
Q1 | $57.6M | Buy |
344,590
+39,864
| +13% | +$6.65M | 0.01% | 966 |
|
|
2020
Q4 | $46.3M | Sell |
304,726
-31,047
| -9% | -$4.07M | 0.01% | 1036 |
|
|
2020
Q3 | $33.9M | Sell |
335,773
-91,656
| -21% | -$10.1M | 0.01% | 1070 |
|
|
2020
Q2 | $51.7M | Buy |
427,429
+374,621
| +709% | +$42.2M | 0.02% | 831 |
|
|
2020
Q1 | $5.01M | Buy |
52,808
+2,817
| +6% | +$268K | ﹤0.01% | 2220 |
|
|
2019
Q4 | $4.4M | Sell |
49,991
-18,550
| -27% | -$1.63M | ﹤0.01% | 2677 |
|
|
2019
Q3 | $5.47M | Sell |
68,541
-80,678
| -54% | -$6.5M | ﹤0.01% | 2469 |
|
|
2019
Q2 | $11.6M | Sell |
149,219
-195,739
| -57% | -$18.3M | ﹤0.01% | 1850 |
|
|
2019
Q1 | $40.5M | Sell |
344,958
-50,459
| -13% | -$5.88M | 0.01% | 1015 |
|
|
2018
Q4 | $43.1M | Sell |
395,417
-76,132
| -16% | -$8.83M | 0.01% | 900 |
|
|
2018
Q3 | $60.3M | Sell |
471,549
-2,892
| -0.6% | -$358K | 0.02% | 829 |
|
|
2018
Q2 | $53.7M | Buy |
474,441
+19,395
| +4% | +$2.13M | 0.02% | 879 |
|
|
2018
Q1 | $51.1M | Sell |
455,046
-289,266
| -39% | -$36.7M | 0.02% | 883 |
|
|
2017
Q4 | $110M | Buy |
744,312
+14,593
| +2% | +$1.86M | 0.03% | 530 |
|
|
2017
Q3 | $85.5M | Sell |
729,719
-915
| -0.1% | -$117K | 0.03% | 615 |
|
|
2017
Q2 | $94.8M | Buy |
730,634
+431,210
| +144% | +$53.8M | 0.03% | 567 |
|
|
2017
Q1 | $40.5M | Sell |
299,424
-118,982
| -28% | -$18M | 0.01% | 959 |
|
|
2016
Q4 | $60M | Buy |
418,406
+396,064
| +1,773% | +$50.6M | 0.02% | 730 |
|
|
2016
Q3 | $2.64M | Sell |
22,342
-5,778
| -21% | -$694K | ﹤0.01% | 2742 |
|
|
2016
Q2 | $2.98M | Buy |
28,120
+5,321
| +23% | +$594K | ﹤0.01% | 2691 |
|
|
2016
Q1 | $2.54M | Sell |
22,799
-7,676
| -25% | -$971K | ﹤0.01% | 2754 |
|
|
2015
Q4 | $4.77M | Buy |
30,475
+9,778
| +47% | +$1.42M | ﹤0.01% | 2359 |
|
|
2015
Q3 | $2.72M | Sell |
20,697
-57,645
| -74% | -$9.25M | ﹤0.01% | 2777 |
|
|
2015
Q2 | $13.6M | Sell |
78,342
-82,039
| -51% | -$14.8M | 0.01% | 1663 |
|
|
2015
Q1 | $27.7M | Sell |
160,381
-19,197
| -11% | -$2.93M | 0.01% | 1124 |
|
|
2014
Q4 | $23.3M | Sell |
179,578
-10,366
| -5% | -$1.34M | 0.01% | 1188 |
|
|
2014
Q3 | $24.4M | Sell |
189,944
-228,485
| -55% | -$23.6M | 0.01% | 1136 |
|
|
2014
Q2 | $37M | Sell |
418,429
-50,188
| -11% | -$4.83M | 0.02% | 933 |
|
|
2014
Q1 | $44.1M | Sell |
468,617
-30,729
| -6% | -$3.14M | 0.02% | 821 |
|
|
2013
Q4 | $56.5M | Sell |
499,346
-62,412
| -11% | -$5.63M | 0.02% | 691 |
|
|
2013
Q3 | $44.3M | Sell |
561,758
-41,964
| -7% | -$3.07M | 0.02% | 746 |
|
|
2013
Q2 | $39.7M | Buy |
+603,722
| New | +$38.9M | 0.02% | 740 |
|
Other funds holding UTHR
ACA
VPM
VCM
Wells Fargo's UTHR Position: Q1 2026 in Review
Wells Fargo reduced its United Therapeutics (UTHR) stake by 15% in Q1 2026, selling an estimated $6.87M and leaving 77,138 shares worth $45.7M. The position accounts for 0.01% of the portfolio, ranked #1019.
Wells Fargo first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $110M in Q4 2017. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Wells Fargo held 77,138 shares of United Therapeutics worth $45.7M as of Q1 2026.
- Wells Fargo sold 13,802 United Therapeutics shares in Q1 2026, an estimated $6.87M.
- United Therapeutics made up 0.01% of Wells Fargo's portfolio in Q1 2026, its #1019 holding.
- Wells Fargo first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's United Therapeutics position peaked at $110M in Q4 2017.
- 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.